The longtime voice of the Dodgers missed his first opening day since 1976 in April due to back fractures. He is now facing a ...

Longer time horizons and therapeutic area expertise make philanthropy venture capital an attractive option for biopharmaceutical companies developing new products. It can also de-risk funding rounds ...

Charley Steiner's multiple myeloma is in remission, marking a significant milestone in his private cancer journey. Jack Jones ...

Longtime broadcaster Charley Steiner revealed to Los Angeles Times columnist Bill Plaschke that his multiple myeloma blood ...

Bionano Genomics (BNGO) announced the publication in Blood Cancer Journal by a group of researchers at the Korea College of Medicine in South ...

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed CAR T-cell therapy as third-line therapy for ...

This study explored the safety and efficacy of a CXCR2 agonist and plerixafor for mobilization of HSCs for hematopoietic stem cell transplantation in patients with MM.

In part 2 of our interview with Surbhi Sidana, MD, MBBS, American Society of Hematology and Stanford University, she delves ...

Dodgers broadcaster Charley Steiner has battled multiple myeloma blood cancer this season, but tells Bill Plaschke he's ...

Publication shows that OGM can resolve translocation partners involving MYC in multiple myeloma (MM) more effectively than current methodsThe ...